{"title":"Acceptability and Determinants of Opportunistic Screening for Breast Cancer in Indian Women.","authors":"Maheshkumar Bhausaheb Jagatap, Ajeet Pratap Maurya, Bharati Pandya, Swagata Brahmachari, Raghvendra Pratap Singh","doi":"10.31557/APJCP.2025.26.1.43","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Screening for breast cancer has been effective in decreasing mortality. Mammography is not readily available in resource-limited countries like India. Annual clinical breast examination has been demonstrated to be as effective as biennial mammography in reducing mortality with much less cost. In absence of an organized systematic screening program opportunity of women visiting the hospital can be used to educate and screen. The current study was designed to assess the acceptability, determinants of acceptability and effectiveness of opportunistic breast cancer screening.</p><p><strong>Methods: </strong>A prospective cross-sectional study was conducted at a tertiary care center in central India. Women of age >35 years with no breast complaints were offered to undergo screening for breast cancer by clinical breast examination. Women with non-breast related complaints or accompanying some other patients were included. Abnormal findings on clinical breast examination were followed by ultrasound (<40 years of age) or mammography (>40 years of age). Standard methods of examination were used. The sample size was 382 and the duration of the study was 2 years.</p><p><strong>Results: </strong>In the study out of 382 participants 255 (66.74%) accepted the examination and 127 denied. Only 66% of participants consented for screening and a lump was detected in seven (2.7%) women. All seven women with breast lump refused further diagnostic work-up. Acceptance of screening was not significantly affected by religion, educational status, marital status and occupation.</p><p><strong>Conclusion: </strong>There was low acceptability to screening, awareness about breast cancer and treatment compliance rates to further management. Acceptability of screening is not affected by socioeconomic or educational status.</p>","PeriodicalId":55451,"journal":{"name":"Asian Pacific Journal of Cancer Prevention","volume":"26 1","pages":"43-47"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Pacific Journal of Cancer Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31557/APJCP.2025.26.1.43","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Screening for breast cancer has been effective in decreasing mortality. Mammography is not readily available in resource-limited countries like India. Annual clinical breast examination has been demonstrated to be as effective as biennial mammography in reducing mortality with much less cost. In absence of an organized systematic screening program opportunity of women visiting the hospital can be used to educate and screen. The current study was designed to assess the acceptability, determinants of acceptability and effectiveness of opportunistic breast cancer screening.
Methods: A prospective cross-sectional study was conducted at a tertiary care center in central India. Women of age >35 years with no breast complaints were offered to undergo screening for breast cancer by clinical breast examination. Women with non-breast related complaints or accompanying some other patients were included. Abnormal findings on clinical breast examination were followed by ultrasound (<40 years of age) or mammography (>40 years of age). Standard methods of examination were used. The sample size was 382 and the duration of the study was 2 years.
Results: In the study out of 382 participants 255 (66.74%) accepted the examination and 127 denied. Only 66% of participants consented for screening and a lump was detected in seven (2.7%) women. All seven women with breast lump refused further diagnostic work-up. Acceptance of screening was not significantly affected by religion, educational status, marital status and occupation.
Conclusion: There was low acceptability to screening, awareness about breast cancer and treatment compliance rates to further management. Acceptability of screening is not affected by socioeconomic or educational status.
期刊介绍:
Cancer is a very complex disease. While many aspects of carcinoge-nesis and oncogenesis are known, cancer control and prevention at the community level is however still in its infancy. Much more work needs to be done and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation.
The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intends to continue to serve in this capacity to the best of its abilities. One of the objectives of the APOCP is to provide all relevant and current scientific information on the whole spectrum of cancer sciences. They aim to do this by providing a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients, through their journal. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensure the highest standards of research communication within the cancer sciences community across Asia as well as globally.
The APJCP publishes original research results under the following categories:
-Epidemiology, detection and screening.
-Cellular research and bio-markers.
-Identification of bio-targets and agents with novel mechanisms of action.
-Optimal clinical use of existing anti-cancer agents, including combination therapies.
-Radiation and surgery.
-Palliative care.
-Patient adherence, quality of life, satisfaction.
-Health economic evaluations.